AMIT KUMAR

About

Postdoctoral researcher at Anatomy and Neuroscience department, University College Cork. I'm currently studying lifestyle interventions to prevent cognitive impairments in subjects with depressive symptoms. I defended my Ph.D. thesis on 6th November, 2025 at Pharmacology & Toxicology Laboratory (CSIR-IHBT), Palampur, India. My work was about treatment-resistant epilepsy and associated comorbidities like depression and cognitive impairment. To carry out this work, I used zebrafish, rats and mice model to screen the dietary intervention.
I did a Master of Pharmacy in Pharmacology from the University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh (2018). My master's thesis was about treatment intervention through glycine transporter inhibitor-1 in a ketamine induced schizophrenia like symptoms.

Employment

• University College Cork Postdoctoral researcher
  2026 - 2028
• Institute of Himalayan Bioresource Technology PhD Student
  2020 - 2025
• University College Cork

Education

• Panjab University M.PHARMACY
  2016 - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Electrospun Rutin/methyl-β-Cyclodextrin/pullulan nanofibers for neuroprotection in a zebrafish model of intracerebral hemorrhage
  Carbohydrate Polymers 2026 DOI: 10.1016/j.carbpol.2026.125679
  +Save
• Nanofibers derived self-assembled liposomes of α-lipoic acid mitigates pentylenetetrazol-induced seizures in zebrafish larvae
  Food Bioscience 2025 DOI: 10.1016/j.fbio.2025.107429
  +Save
• Embryonic exposure to flaxseed oil during early development protects against seizures in zebrafish larvae via targeting BDNF/TrkB-mediated GABAergic inhibition
  Food Bioscience 2025 DOI: 10.1016/j.fbio.2025.106701
  +Save
• Medium‐Chain Triglycerides Supplementation Protects Epilepsy‐Associated Behavioral Impairments in a Mouse Model
  Journal of Biochemical and Molecular Toxicology 2025 DOI: 10.1002/jbt.70213
  +Save
• Targeting Alzheimer's Disease Using Neurotrophic Agents and Mimetics: Current Strategies and Challenges
  Alzheimers Disease Diagnosis Molecular Targets and Therapeutic Modalities 2025 DOI: 10.1201/9781003602477-13
  +Save
• Temporal Dynamics of c-Fos Expression in a Zebrafish Larva Model of Pentylenetetrazole-Induced Seizures
  Zebrafish 2025 DOI: 10.1177/15458547251401472
  +Save
• Sarcosine (glycine transporter inhibitor) attenuates behavioural and biochemical changes induced by ketamine, in the rat model of schizophrenia.
  Experimental brain research 2022 DOI: 10.1007/s00221-022-06530-4
  +Save
• Insights into the Cellular Interactions and Molecular Mechanisms of Ketogenic Diet for Comprehensive Management of Epilepsy.
  Current neuropharmacology 2022 DOI: 10.2174/1570159x20666220420130109
  +Save
• Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
  Cytokine & growth factor reviews 2020 DOI: 10.1016/j.cytogfr.2020.08.002
  +Save
• Dietary Flavonoids Interaction with CREB-BDNF Pathway: An Unconventional Approach for Comprehensive Management of Epilepsy.
  Current neuropharmacology 2019 DOI: 10.2174/1570159x17666190809165549
  +Save